Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Ann Lin, Christopher J. Giuliano, Ann Palladino, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 509
Open Access | Times Cited: 596

Showing 1-25 of 596 citing articles:

The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions
Rose Oughtred, Jennifer Rust, Christie Chang, et al.
Protein Science (2020) Vol. 30, Iss. 1, pp. 187-200
Open Access | Times Cited: 1221
Why 90% of clinical drug development fails and how to improve it?
Duxin Sun, Wei Gao, Hongxiang Hu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3049-3062
Open Access | Times Cited: 870
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R. McDevitt, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 589-608
Open Access | Times Cited: 632
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Ying Zhou, Yintao Zhang, Xichen Lian, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1398-D1407
Open Access | Times Cited: 501
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
Attila A. Seyhan
Translational Medicine Communications (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 500
Small molecules, big impact: 20 years of targeted therapy in oncology
Philippe L. Bédard, David M. Hyman, Matthew S. Davids, et al.
The Lancet (2020) Vol. 395, Iss. 10229, pp. 1078-1088
Closed Access | Times Cited: 459
Diversity and versatility of p38 kinase signalling in health and disease
Begoña Cánovas, Ángel R. Nebreda
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 5, pp. 346-366
Open Access | Times Cited: 429
Targeting RNA structures with small molecules
Jessica L. Childs‐Disney, Xueyi Yang, Quentin M. R. Gibaut, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 736-762
Open Access | Times Cited: 353
Design of therapeutic biomaterials to control inflammation
Zhaoxu Tu, Yiling Zhong, Hanze Hu, et al.
Nature Reviews Materials (2022) Vol. 7, Iss. 7, pp. 557-574
Open Access | Times Cited: 316
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 291
Advances in covalent kinase inhibitors
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 256
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou, David A. Quigley, Troy M. Robinson, et al.
Cancer Discovery (2020) Vol. 10, Iss. 3, pp. 351-370
Open Access | Times Cited: 235
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
Andreas Bender, Isidro Cortés‐Ciriano
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 511-524
Open Access | Times Cited: 226
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 193
DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy
Hui Liu, Wenhao Zhang, Bo Zou, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 188
Current understanding of biological identity at the nanoscale and future prospects
Kenneth A. Dawson, Yan Yan
Nature Nanotechnology (2021) Vol. 16, Iss. 3, pp. 229-242
Open Access | Times Cited: 157
Small‐Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery
Guanting Li, Bingjun Sun, Yaqiao Li, et al.
Small (2021) Vol. 17, Iss. 52
Closed Access | Times Cited: 155
Improving target assessment in biomedical research: the GOT-IT recommendations
Christoph H. Emmerich, Lorena Martinez‐Gamboa, M. Hofmann, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 64-81
Open Access | Times Cited: 153
3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
Mélanie A. G. Barbosa, Cristina P. R. Xavier, Rúben F. Pereira, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 190-190
Open Access | Times Cited: 151
AI in drug discovery and its clinical relevance
Rizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17575-e17575
Open Access | Times Cited: 150
Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients
JungHo Kong, Heetak Lee, Donghyo Kim, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 144
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
Peter M. Bruno, Mengrou Lu, Kady A. Dennis, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 8, pp. 4053-4060
Open Access | Times Cited: 143
Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
Xuefei Wang, Duan Ni, Yaqin Liu, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 111
Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review
Sze Wan Hung, Ruizhe Zhang, Zhouyurong Tan, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 4, pp. 2489-2564
Open Access | Times Cited: 108
Oncogene-like addiction to aneuploidy in human cancers
Vishruth Girish, Asad A. Lakhani, Sarah L. Thompson, et al.
Science (2023) Vol. 381, Iss. 6660
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top